Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.17240 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Noam Sugar and 2 co-authors. Institution: Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel. Major MEDLINE topics: Cat Diseases. Cited 6 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Primary glomerular disease resulting in protein-losing nephropathy (PLN) is an uncommon cause of chronic kidney disease in cats, yet is important to recognize because it warrants specific treatment that impacts outcome. Hypothesis/Objective Characterize clinicopathologic findings, prognostic indicators, and short- (≤30 days) and long-term survival of cats with PLN. Animals Thirty-seven cats with naturally occurring PLN.
Methods
Medical records of cats with PLN admitted to a veterinary teaching hospital were retrospectively reviewed.
Results
Median age was 3 years (range, 1.5-11.5 years) and 17/37 (46%) were males. Short-term survival was 57%. The estimated median survival time of all cats was 424 days (95% confidence interval [CI], 0-1098 days). Common clinical signs included lethargy (57%), edema (46%) and weight loss (35%). Edema was more common in short-term survivors compared with nonsurvivors (odds ratio [OR], 0.21; 95% CI, 0.05-0.86-20.4; P = .04). Serum creatinine concentration at presentation was negatively associated with long-term survival (OR, 1.3; 95% CI, 1.03-1.52; P = .01). Administration of immunosuppressive and antiproteinuric medications was more common among short-term survivors compared with nonsurvivors (18/20 [90%] vs 9/16 [56%]; OR, 7.0; 95% CI, 1.2-40.8; P = .05 and 17/20 [85%] vs 7/16 [44%]; OR, 7.3; 95% CI, 1.5-35.2; P = .01, respectively). Partial or complete remission was documented in 11/31 (36%) cats and was associated with both short (OR, 3.3; 95% CI, 1.7-6.5; P < .001) and long-term survival (P = .003). Conclusion and Clinical Importance Cats with PLN have a guarded prognosis, but achieving remission improves outcome. Cats presented with edema rather than azotemia are more likely to respond to treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel.
ORCID profiles: Hilla Chen, Gilad Segev
Cite
APA
Sugar, N., Chen, H., & Segev, G. (2024). Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17240
Vancouver
Sugar N, Chen H, Segev G. Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17240
BibTeX
@article{Sugar2024,
author = {Sugar, Noam and Chen, Hilla and Segev, Gilad},
title = {Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.17240}
}
EUVIMED